| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | 
|---|---|---|---|---|---|---|
Income Statement  | ||||||
| Total Revenue | 179.32M | 166.71M | 268.72M | 270.88M | 140.76M | 93.07M | 
| Gross Profit | 48.28M | 28.89M | 85.28M | 112.95M | 61.18M | 37.91M | 
| EBITDA | 9.21M | -8.34M | 43.34M | 67.23M | 28.04M | 11.58M | 
| Net Income | 200.00K | -12.45M | 32.53M | 49.36M | 20.33M | 7.29M | 
Balance Sheet  | ||||||
| Total Assets | 314.71M | 315.27M | 355.52M | 229.13M | 125.91M | 95.30M | 
| Cash, Cash Equivalents and Short-Term Investments | 117.23M | 130.99M | 168.11M | 22.45M | 23.59M | 27.03M | 
| Total Debt | 21.67M | 18.36M | 16.48M | 36.85M | 2.53M | 2.79M | 
| Total Liabilities | 50.23M | 39.51M | 40.35M | 81.55M | 22.09M | 12.54M | 
| Stockholders Equity | 264.48M | 275.76M | 315.16M | 147.58M | 103.82M | 82.75M | 
Cash Flow  | ||||||
| Free Cash Flow | 22.70M | 12.66M | 11.63M | -8.15M | 8.86M | 4.85M | 
| Operating Cash Flow | 31.88M | 22.22M | 20.01M | 1.00M | 10.90M | 6.66M | 
| Investing Cash Flow | -7.16M | -6.90M | -112.25M | -8.20M | -13.60M | -41.13K | 
| Financing Cash Flow | -16.23M | -36.91M | 113.42M | 10.65M | -536.00K | -246.73K | 
Name  | Overall Rating  | Market Cap  | P/E Ratio  | ROE  | Dividend Yield  | Revenue Growth  | EPS Growth  | 
|---|---|---|---|---|---|---|---|
| ― | $278.94M | 24.37 | 39.51% | ― | 4.63% | 328.61% | |
| ― | $931.06M | 36.95 | 7.49% | ― | 19.67% | 12.32% | |
| ― | $230.98M | 16.97 | 8.61% | ― | 5.06% | 29.66% | |
| ― | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
| ― | $487.35M | 1,961.11 | 0.07% | ― | 5.72% | ― | |
| ― | $319.54M | 274.29 | 0.52% | ― | 6.50% | -88.62% | |
| ― | $74.06M | ― | -30.53% | ― | 58.04% | 21.09% | 
On October 28, 2025, Clearfield, Inc. announced the appointment of Rebecca B. Seidel and Kathleen S. Skarvan to its Board of Directors, effective December 10, 2025. This strategic move aims to enhance the board’s collective strength and support Clearfield’s long-term growth. Both appointees bring extensive experience in their respective fields, with Ms. Seidel having a strong background in MedTech and Ms. Skarvan in high technology and strategic leadership. Their appointments coincide with the retirement of current directors Charles N. Hayssen and Donald R. Hayward, who will step down at the 2026 annual meeting of shareholders. This transition is expected to bolster Clearfield’s strategic direction and operational excellence, potentially impacting stakeholders positively by driving growth and innovation.
The most recent analyst rating on (CLFD) stock is a Buy with a $52.00 price target. To see the full list of analyst forecasts on Clearfield stock, see the CLFD Stock Forecast page.
The recent earnings call for Clearfield painted a picture of robust growth and strategic innovation, tempered by some ongoing challenges. The company reported strong performance in its Clearfield segment, significant improvements in gross margins, and successful product innovations. However, it also acknowledged hurdles in the Nestor segment, delays in BEAD funding, and persistent supply chain issues.
Clearfield, Inc. is a company specializing in the design, manufacture, and distribution of fiber optic management, protection, and delivery products, primarily serving the communications networks sector. In its third quarter fiscal 2025 earnings report, Clearfield reported a revenue of $49.9 million, marking a 15% year-over-year growth in its Clearfield Segment, and a net income per share of $0.11, which exceeded the top end of its guidance range. The company also announced an increase in its full-year revenue guidance to a range of $180 million to $184 million.